Dr. Lynette Posorske, MD

Infectious Disease Silver Spring, MD Female
NPI: 1598728305
Total Payments
$79,479
2024 Payments
$1,643
Companies
24
Transactions
816
Medicare Patients
2,061
Medicare Billing
$260,583

Payment Breakdown by Category

Other$53,943 (67.9%)
Food & Beverage$18,278 (23.0%)
Travel$7,021 (8.8%)
Education$237.31 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $53,943 35 67.9%
Food and Beverage $18,278 728 23.0%
Travel and Lodging $7,021 43 8.8%
Education $237.31 10 0.3%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $44,352 314 $0 (2024)
Merck Sharp & Dohme LLC $25,808 119 $0 (2024)
ViiV Healthcare Company $4,263 174 $0 (2024)
Janssen Biotech, Inc. $1,389 64 $0 (2023)
ABBVIE INC. $925.89 38 $0 (2024)
Theratechnologies Inc. $662.19 24 $0 (2024)
Insmed, Inc. $558.65 19 $0 (2024)
Janssen Products, LP $365.26 7 $0 (2020)
Napo Pharmaceuticals Inc $228.02 9 $0 (2022)
Allergan, Inc. $191.74 10 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,643 72 Gilead Sciences, Inc. ($673.27)
2023 $1,704 80 ViiV Healthcare Company ($643.85)
2022 $4,341 97 Gilead Sciences, Inc. ($3,298)
2021 $8,764 114 Gilead Sciences, Inc. ($7,129)
2020 $2,852 74 Gilead Sciences, Inc. ($1,831)
2019 $27,569 161 Merck Sharp & Dohme Corporation ($13,208)
2018 $18,791 106 Gilead Sciences, Inc. ($9,523)
2017 $13,816 112 Gilead Sciences Inc ($8,657)

All Payment Transactions

816 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
12/19/2024 ViiV Healthcare Company RUKOBIA (Drug) Food and Beverage In-kind items and services $27.27 General
Category: HIV
12/17/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $15.73 General
11/25/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $16.89 General
Category: HIV
11/21/2024 Novartis Pharmaceuticals Corporation ILARIS (Drug) Food and Beverage In-kind items and services $27.40 General
Category: Immunology
11/20/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $18.71 General
11/12/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $17.88 General
11/06/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $25.74 General
Category: HIV
11/06/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $18.27 General
11/06/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $14.29 General
Category: HIV
11/05/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $13.12 General
Category: INFECTIOUS DISEASE
10/25/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $33.05 General
10/22/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $131.62 General
10/18/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $21.39 General
10/15/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $19.14 General
10/10/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $21.33 General
Category: HIV
10/02/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $19.77 General
Category: HIV
09/24/2024 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $22.53 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
09/17/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $20.37 General
09/12/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZINPLAVA, ZERBAXA Food and Beverage In-kind items and services $18.11 General
Category: INFECTIOUS DISEASE
09/10/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $12.92 General
Category: INFECTIOUS DISEASE
09/04/2024 ViiV Healthcare Company RUKOBIA (Drug) Food and Beverage In-kind items and services $18.75 General
Category: HIV
08/29/2024 ABBVIE INC. AVYCAZ (Drug), DALVANCE, TEFLARO Food and Beverage In-kind items and services $13.38 General
Category: ANTI-INFECTIVE
08/28/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $26.65 General
08/28/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $23.60 General
08/28/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $19.09 General
Category: HIV
123…33»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 656 994 $284,243 $92,081
2022 9 520 723 $198,728 $61,344
2021 9 534 794 $204,110 $67,146
2020 9 351 494 $134,346 $40,011
Total Patients
2,061
Total Services
3,005
Medicare Billing
$260,583
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 142 275 $78,650 $28,292 36.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 182 323 $64,277 $21,739 33.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 109 117 $44,577 $13,252 29.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 85 132 $40,128 $12,409 30.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 33 34 $19,074 $5,029 26.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 26 31 $12,555 $4,309 34.3%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 41 42 $11,802 $3,048 25.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 19 19 $8,854 $2,703 30.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 19 21 $4,326 $1,299 30.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 185 286 $56,914 $17,138 30.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 71 124 $37,696 $12,534 33.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 100 139 $39,754 $11,749 29.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 63 64 $24,384 $7,446 30.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 19 19 $10,659 $3,319 31.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 19 20 $8,100 $3,006 37.1%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 28 29 $8,149 $2,398 29.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $7,922 $2,034 25.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 18 25 $5,150 $1,720 33.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 216 390 $77,610 $24,928 32.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 78 124 $37,696 $13,238 35.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 69 99 $28,314 $9,155 32.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 64 66 $25,146 $7,842 31.2%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 33 34 $9,554 $3,122 32.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 15 16 $6,480 $2,547 39.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 27 33 $6,798 $2,520 37.1%
12»

About Dr. Lynette Posorske, MD

Dr. Lynette Posorske, MD is a Infectious Disease healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598728305.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynette Posorske, MD has received a total of $79,479 in payments from pharmaceutical and medical device companies, with $1,643 received in 2024. These payments were reported across 816 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,943).

As a Medicare-enrolled provider, Posorske has provided services to 2,061 Medicare beneficiaries, totaling 3,005 services with total Medicare billing of $260,583. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Infectious Disease
  • Location Silver Spring, MD
  • Active Since 04/11/2006
  • Last Updated 03/01/2011
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1598728305

Products in Payments

  • Biktarvy (Drug) $13,067
  • ZERBAXA (Drug) $11,296
  • DIFICID (Drug) $11,254
  • Veklury (Drug) $9,172
  • Genvoya (Drug) $4,405
  • DOVATO (Drug) $1,786
  • Descovy (Drug) $1,719
  • CABENUVA (Biological) $928.53
  • TRIUMEQ (Drug) $666.36
  • Arikayce (Drug) $558.65
  • PREZCOBIX (Drug) $530.72
  • Symtuza (Drug) $482.54
  • AVYCAZ (Drug) $447.47
  • SYMTUZA (Drug) $427.34
  • Truvada (Drug) $341.00
  • TROGARZO (Drug) $339.76
  • JULUCA (Drug) $322.71
  • EGRIFTA (Drug) $322.43
  • ISENTRESS (Drug) $275.77
  • RUKOBIA (Drug) $263.57

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Silver Spring

Dr. Phuong Trinh

Infectious Disease — Payments: $220,875

Infectious Disease $220,875

Michael Koren, M.d, M.D

Infectious Disease — Payments: $106,100

Infectious Disease $106,100

Barbara Matthews, Md, Mph, MD, MPH

Infectious Disease — Payments: $36,685

Infectious Disease $36,685

Mrs. Rebecca Shaffer, Md, MD

Infectious Disease — Payments: $9,143

Infectious Disease $9,143

Vasilios Pyrgos, Md, MD

Infectious Disease — Payments: $7,622

Infectious Disease $7,622

Dr. John Mcneil, M.d, M.D

Infectious Disease — Payments: $1,655

Infectious Disease $1,655